Table 1. Clinical details of T2DM patients and the healthy controls.
| Characteristics | T2DM Cases (n = 250) | Healthy Controls (n = 250) | p value |
|---|---|---|---|
| Age (Years) | 41–82 (57.19 ± 8.22) | 41–60 (53.93 ± 6.32) | 0.0003 |
| Males/Females (%) | 138 (55.2%)/112 (44.8%) | 144 (57.6%)/106(42.4%) | 0.3461 |
| BMI (kg/m2) | 27.5 ± 4.1 | 25.8 ± 3.9 | 0.4306 |
| T2DM Interval | 13.1 ± 6.3 | NA | NA |
| FBS (mg/dL) | 143.61 ± 55.66 | 93.54 ± 12.13 | 0.0001 |
| PPBG (mg/dL) | 201.29 ± 25.25 | 117.29 ± 19.07 | 0.0001 |
| TG (mg/dL) | 156.42 ± 78.97 | 138.77 ± 53.69 | 0.0001 |
| TC (mg/dL) | 183.95 ± 51.54 | 175.06 ± 33.05 | 0.0001 |
| HDL-C (mg/dL) | 88.72 ± 23.1 | 82.61 ± 20.6 | 0.01 |
| LDL-C (mg/dL) | 38.76 ± 4.4 | 35.53 ± 4.1 | 0.2658 |
| Family History, n (%) | 146 (58.4%) | 138 (55.2%) | 0.3745 |
NA = Not Analyzed/ Not Applicable.